$2.45
-0.10[-3.92%]
At close: Apr 26
$2.45
0[0.00%]
After Hours: 6:23PM EDT
Heron Therapeutics
(NASDAQ:HRTX)Heron Therapeutics Stock (NASDAQ:HRTX), Analyst Ratings, Price Targets, Predictions
Heron Therapeutics Inc has a consensus price target of $7, established from looking at the 13 latest analyst ratings. The last 3 analyst ratings were released from Capital One, Needham, and Needham on April 23, 2024, April 11, 2024, and March 13, 2024. With an average price target of $5.33 between Capital One, Needham, and Needham, there's an implied 117.69% upside for Heron Therapeutics Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Capital One
Needham
Evercore ISI Group
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Heron Therapeutics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/23/2024 | HRTX | Buy Now | Heron Therapeutics | $2.45 | 144.9% | Capital One | Tim Chiang | → $6 | Initiates | → Overweight | Get Alert |
| 04/11/2024 | HRTX | Buy Now | Heron Therapeutics | $2.45 | 104.08% | Needham | Serge Belanger | → $5 | Reiterates | Buy → Buy | Get Alert |
| 03/13/2024 | HRTX | Buy Now | Heron Therapeutics | $2.45 | 104.08% | Needham | Serge Belanger | $4 → $5 | Maintains | Buy | Get Alert |
| 11/15/2023 | HRTX | Buy Now | Heron Therapeutics | $2.45 | 63.27% | Needham | Serge Belanger | $5 → $4 | Maintains | Buy | Get Alert |
| 08/15/2023 | HRTX | Buy Now | Heron Therapeutics | $2.45 | 104.08% | Needham | Serge Belanger | → $5 | Reiterates | Buy → Buy | Get Alert |
| 07/25/2023 | HRTX | Buy Now | Heron Therapeutics | $2.45 | 104.08% | Needham | Serge Belanger | $6 → $5 | Maintains | Buy | Get Alert |
| 05/12/2023 | HRTX | Buy Now | Heron Therapeutics | $2.45 | 144.9% | Needham | Serge Belanger | $7 → $6 | Maintains | Buy | Get Alert |
| 04/21/2023 | HRTX | Buy Now | Heron Therapeutics | $2.45 | 185.71% | Needham | Serge Belanger | → $7 | Reiterates | → Buy | Get Alert |
| 03/24/2023 | HRTX | Buy Now | Heron Therapeutics | $2.45 | 308.16% | Evercore ISI Group | Shweta Khajuria | $15 → $10 | Maintains | Outperform | Get Alert |
| 03/24/2023 | HRTX | Buy Now | Heron Therapeutics | $2.45 | 185.71% | Needham | Serge Belanger | $8 → $7 | Maintains | Buy | Get Alert |
| 11/09/2022 | HRTX | Buy Now | Heron Therapeutics | $2.45 | 226.53% | Needham | Serge Belanger | $10 → $8 | Maintains | Buy | Get Alert |
| 06/30/2022 | HRTX | Buy Now | Heron Therapeutics | $2.45 | 308.16% | Needham | Serge Belanger | $14 → $10 | Maintains | Buy | Get Alert |
| 05/10/2022 | HRTX | Buy Now | Heron Therapeutics | $2.45 | 471.43% | Needham | Serge Belanger | $16 → $14 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Heron Therapeutics (HRTX)?
The latest price target for Heron Therapeutics (NASDAQ: HRTX) was reported by Capital One on April 23, 2024. The analyst firm set a price target for $6.00 expecting HRTX to rise to within 12 months (a possible 144.90% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Heron Therapeutics (HRTX)?
The latest analyst rating for Heron Therapeutics (NASDAQ: HRTX) was provided by Capital One, and Heron Therapeutics initiated their overweight rating.
When was the last upgrade for Heron Therapeutics (HRTX)?
There is no last upgrade for Heron Therapeutics.
When was the last downgrade for Heron Therapeutics (HRTX)?
There is no last downgrade for Heron Therapeutics.
When is the next analyst rating going to be posted or updated for Heron Therapeutics (HRTX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Heron Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Heron Therapeutics was filed on April 23, 2024 so you should expect the next rating to be made available sometime around April 23, 2025.
Is the Analyst Rating Heron Therapeutics (HRTX) correct?
While ratings are subjective and will change, the latest Heron Therapeutics (HRTX) rating was a initiated with a price target of $0.00 to $6.00. The current price Heron Therapeutics (HRTX) is trading at is $2.45, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.